spacer
home > pmps > summer 2017 > supply uninterrupted
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Uninterrupted

The biopharmaceutical manufacturing sector is adopting new technologies and consumables at a fast pace to meet growth demands and increase flexibility. At the same time, regulatory authorities are putting pressure on biomanufacturers to have control over their full supply chains. Indeed, both manufacturers and industry working groups are placing increased emphasis on raw material and supplier management to help protect patients, enhance transparency and minimise risk (1-4). Additional concerns centre around events that might interrupt the supply of components needed to manufacture human health products.

Some suppliers are responding by investing in strategies, in-house expertise and human and system resources to help biomanufacturers meet these needs, but others are not as responsive. When choosing suppliers, a structured and risk-based approach is important.

A Holistic Approach


Ensuring that materials are available when needed is a key aspect of a supply chain security programme, but it is not sufficient for suppliers to focus on this alone. The products must maintain a high level of quality each time, and any changes must be communicated in a punctual and transparent manner. A comprehensive supply security strategy addresses these needs. One example of a holistic approach is based on three interrelated concepts (see Figure 1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Employed by GE Healthcare since 2001, Elles Steensma is the Global Product Manager for Security of Supply for chromatography resins. Her prior roles at the company include Protein Scientist in R&D and Quality Control Manager within Global Supply Chain. At Wageningen University, The Netherlands, Elles earned a BSc and MSc in molecular sciences as well as a PhD in biochemistry. She joined GE Healthcare after several years as a postdoctoral researcher at Uppsala University, Sweden.
spacer
Elles Steensma
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. This latest extension includes grants from MJFF to support two projects:
More info >>

White Papers

Transforming Temperature Data Management Practices to Reduce Labor Costs and Improve Visibility and Control

Berlinger & Co AG

There are a number of temperature monitoring database options available to the biopharma supply chain professional and choosing the right one can significantly improve workflow which will reduce administrative time. This article will provide insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. Additionally, it describes the unique features and benefits of the Berlinger Smartview® data management system. Smartview® is a “Software as a Service” (SaaS) platform designed to efficiently and accurately manage both workflow and data in a regulatory compliant manner (21 CRF Part 11 & Annex 11). This comprehensive temperature data management system ensures reliability, accuracy, security, accessibility, and visibility to supply chain professionals, enhancing Good Distribution Practices (GDP) of temperature sensitive shipments.
More info >>

 
Industry Events

SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast

6-8 June 2018, Crowne Plaza, San Diego, CA, USA

SMi proudly presents the 2nd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on the 7th and 8th of June 2018. Delivering updates and promoting discussion on key challenges and developments within the pharmaceutical microbiology industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement